MA44859A - Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes - Google Patents

Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes

Info

Publication number
MA44859A
MA44859A MA044859A MA44859A MA44859A MA 44859 A MA44859 A MA 44859A MA 044859 A MA044859 A MA 044859A MA 44859 A MA44859 A MA 44859A MA 44859 A MA44859 A MA 44859A
Authority
MA
Morocco
Prior art keywords
pseudodimers
oxazoline
pharmaceutical compositions
related use
pharmaceutical
Prior art date
Application number
MA044859A
Other languages
English (en)
Inventor
Paul Blake
Laykea Tafesse
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of MA44859A publication Critical patent/MA44859A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MA044859A 2016-05-04 2017-05-04 Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes MA44859A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662331710P 2016-05-04 2016-05-04

Publications (1)

Publication Number Publication Date
MA44859A true MA44859A (fr) 2019-03-13

Family

ID=58709615

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044859A MA44859A (fr) 2016-05-04 2017-05-04 Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes

Country Status (6)

Country Link
US (1) US10858326B2 (fr)
EP (1) EP3452473A1 (fr)
JP (1) JP2019514960A (fr)
CN (1) CN109071518A (fr)
MA (1) MA44859A (fr)
WO (1) WO2017192858A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA44859A (fr) 2016-05-04 2019-03-13 Purdue Pharma Lp Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes
JP2019517524A (ja) * 2016-06-02 2019-06-24 パーデュー ファーマ エルピー 疼痛治療のための微量アミン関連受容体１アゴニスト及び部分アゴニスト

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
CN101600700B (zh) 2007-02-02 2013-08-21 弗·哈夫曼-拉罗切有限公司 作为taar1配体用于cns病症的新的2-氨基噁唑啉
KR101222412B1 (ko) 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
CN102083805A (zh) * 2008-07-24 2011-06-01 弗·哈夫曼-拉罗切有限公司 4,5-二氢-唑-2-基衍生物
US20100311798A1 (en) 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US9132136B2 (en) * 2010-08-02 2015-09-15 Hoffmann-La Roche Inc. Pharmaceutical combination
US8673950B2 (en) * 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US8802673B2 (en) * 2011-03-24 2014-08-12 Hoffmann-La Roche Inc Heterocyclic amine derivatives
CA2856204A1 (fr) * 2012-01-12 2013-07-18 F. Hoffmann-La Roche Ag Derives heterocycliques utilises comme recepteurs associes a des amines sous forme de trace (taar)
MA44859A (fr) 2016-05-04 2019-03-13 Purdue Pharma Lp Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes

Also Published As

Publication number Publication date
CN109071518A (zh) 2018-12-21
JP2019514960A (ja) 2019-06-06
EP3452473A1 (fr) 2019-03-13
WO2017192858A1 (fr) 2017-11-09
US20190144400A1 (en) 2019-05-16
US10858326B2 (en) 2020-12-08

Similar Documents

Publication Publication Date Title
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
EP3313404A4 (fr) Compositions thérapeutiques, associations et procédés d'utilisation
EP3436482A4 (fr) Anticorps, compositions pharmaceutiques et procédés
EP3450460A4 (fr) Conjugué de liaison multi-spécifique, compositions pharmaceutiques associées et utilisation
MA44740A (fr) Variantes de capsides de virus adéno-associé et leurs procédés d'utilisation
IL264065A (en) Oral gastroretentive formulations and uses thes thereof
HUE053737T2 (hu) Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik
EP3479841A4 (fr) Dérivé du glucagon, conjugué de celui-ci, composition le comprenant et utilisation thérapeutique de celui-ci
EP3500255A4 (fr) Compositions pharmaceutiques ophtalmiques et utilisations associées
PL3603620T3 (pl) Kompozycja liposomowa i kompozycja farmaceutyczna
MA46867A (fr) Formulations pharmaceutiques
HUE071358T2 (hu) Benzolszulfonamid vegyületek és terápiás szerként való alkalmazásuk
EP3380525A4 (fr) Formulations pharmaceutiques et leurs procédés d'utilisation
MA52648A (fr) Agonistes de ppar, composés, compositions pharmaceutiques et leurs procédés d'utilisation
DK3412660T3 (da) Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme
EP3328800A4 (fr) Compositions polymères inhibant le tartre, mélanges et leurs méthodes d'utilisation
EP3334719A4 (fr) Benzimidazoles substitués, préparation et utilisation de ceux-ci en tant qu'agents pharmaceutiques
EP3496768A4 (fr) Compositions antimicrobiennes et procédés d'utilisation associés.
EP3434666A4 (fr) Dérivé d'arylamine et utilisation correspondante
EP3664797A4 (fr) Ligands de nr4a1, compositions pharmaceutiques et procédés d'utilisation associés
EP3373907A4 (fr) Compositions pharmaceutiques à libération prolongée et méthodes d'utilisation
IL282157A (en) Compounds and therapeutic uses thereof
MA49837A (fr) Compositions pharmaceutiques
EP3476864A4 (fr) Anticorps dirigé contre etar, composition pharmaceutique et utilisation associées
MA40524A (fr) Dérivés d'adrénomédulline stabilisés et leur utilisation